Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors

Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors

US Patent 12319702 · Granted Jun 3, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bolter miner and tunneling system2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof2024
Substituted furanopyrimidine compounds as PDE1 inhibitors2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonis2023
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto2023
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2023
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2023